Recent advances in the study of hepatitis B virus covalently closed circular DNA

被引:13
|
作者
Ji, Mengying [1 ]
Hu, Kanghong [1 ]
机构
[1] Hubei Univ Technol, Natl Ctr Cellular Regulat & Mol Pharmaceut 111, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Sino German Biomed Ctr,Key Lab Fermentat Engn,Min, Wuhan 430068, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
hepatitis B virus (HBV); covalently closed circular DNA (cccDNA); HBx; immune-mediated; genome-editing nucleases; EPIGENETIC REGULATION; HBV REPLICATION; HUMAN-CELLS; STEM-CELLS; CCCDNA; REPAIR; CRISPR/CAS9; PROTEIN; DEGRADATION; PERSISTENCE;
D O I
10.1007/s12250-017-4009-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis B infection is caused by hepatitis B virus (HBV) and a total cure is yet to be achieved. The viral covalently closed circular DNA (cccDNA) is the key to establish a persistent infection within hepatocytes. Current antiviral strategies have no effect on the pre-existing cccDNA reservoir. Therefore, the study of the molecular mechanism of cccDNA formation is becoming a major focus of HBV research. This review summarizes the current advances in cccDNA molecular biology and the latest studies on the elimination or inactivation of cccDNA, including three major areas: (1) epigenetic regulation of cccDNA by HBV X protein, (2) immune-mediated degradation, and (3) genome-editing nucleases. All these aspects provide clues on how to finally attain a cure for chronic hepatitis B infection.
引用
收藏
页码:454 / 464
页数:11
相关论文
共 50 条
  • [41] Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients
    Wang, Lin
    Cao, Xi
    Wang, Zhenzi
    Gao, Yuhua
    Deng, Juan
    Liu, Xueen
    Zhuang, Hui
    JOURNAL OF CLINICAL MICROBIOLOGY, 2019, 57 (01)
  • [42] Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma
    Luo, Xuan
    Huang, Yao
    Chen, Yanmeng
    Tu, Zeng
    Hu, Jieli
    Tavis, John E.
    Huang, Ailong
    Hu, Yuan
    PLOS ONE, 2016, 11 (06):
  • [43] Quantification of Hepatitis B Virus Covalently Closed Circular DNA in Infected Cell Culture Models by Quantitative PCR
    Qu, Bingqian
    Urban, Stephan
    BIO-PROTOCOL, 2019, 9 (07):
  • [44] Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
    Ahmed, Marawan
    Wang, Feng
    Levin, Aviad
    Le, Connie
    Eltayebi, Yomna
    Houghton, Michael
    Tyrrell, Lorne
    Barakat, Khaled
    DRUG DISCOVERY TODAY, 2015, 20 (05) : 548 - 561
  • [45] Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation
    Hong, Xupeng
    Hu, Jianming
    JOURNAL OF VIROLOGY, 2022, 96 (15)
  • [46] Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
    Cai, Dawei
    Mills, Courtney
    Yu, Wenquan
    Yan, Ran
    Aldrich, Carol E.
    Saputelli, Jeffry R.
    Mason, William S.
    Xu, Xiaodong
    Guo, Ju-Tao
    Block, Timothy M.
    Cuconati, Andrea
    Guo, Haitao
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4277 - 4288
  • [47] Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients
    Huang, Qi
    Zhou, Bin
    Cai, Dawei
    Zong, Yuhua
    Wu, Yaobo
    Liu, Shi
    Mercier, Alexandre
    Guo, Haitao
    Hou, Jinlin
    Colonno, Richard
    Sun, Jian
    HEPATOLOGY, 2021, 73 (01) : 41 - 52
  • [48] CRISPR-Cas9 Targeting of Hepatitis B Virus Covalently Closed Circular DNA Generates Transcriptionally Active Episomal Variants
    Martinez, Maria Guadalupe
    Combe, Emmanuel
    Inchauspe, Aurore
    Mangeot, Philippe Emmanuel
    Delberghe, Elodie
    Chapus, Fleur
    Neveu, Gregory
    Alam, Antoine
    Carter, Kara
    Testoni, Barbara
    Zoulim, Fabien
    MBIO, 2022, 13 (02):
  • [49] Classifying hepatitis B therapies with insights from covalently closed circular DNA dynamics
    Hu, Jie-Li
    Huang, Ai-Long
    VIROLOGICA SINICA, 2024, 39 (01) : 9 - 23
  • [50] The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in "Site"?
    Block, Timothy M.
    Guo, Ju-Tao
    GASTROENTEROLOGY, 2016, 150 (01) : 34 - 36